SIMPLE, FAST, RELIABLE
Products
Comprehensive diagnostic product portfolio for emergency and point-of-care diagnostics.
DIAGENICS has patent-protected antibodies to this enzyme and has already developed a new product line for early diagnosis of preeclampsia: DIANEONATAL.®Current and future studies will further expand our expertise in the field of preeclampsia diagnosis.
Diagenics has patented antibodies to this enzyme and has already developed a new line of products for the early diagnosis of stroke: DIASTROKE®. The product was CE registered based on a study. Future studies will expand our expertise in stroke diagnosis.
DIAGENICS has patented antibodies to this enzyme and has already developed a new product line for the early diagnosis of chest pain patients for the detection of heart attacks: DIACORDON®. Current and future studies will also expand our knowledge in the field of heart attack diagnosis and the success of the course of treatment (monitoring).
All organizations and companies have adapted to the pandemic and have already taken important steps to reduce the likelihood of COVID-19 infection in the team. Masks, social distance, changing workplaces to home office and other measures have been already established to protect infections within the team as well as customers and business partners.